Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low
Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.
Customise key ratios, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
In last 3 months, mutual fund holding of the company has almost stayed constant
2 weeks ago•Business Standard
2 weeks ago•Economic Times
3 weeks ago•Bloomberg Quint
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated August 16, 2019, titled "Sun Pharma and China Medical System Holdings Enter into Licensing Agreement for Generic Products in Mainland China".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated August 14, 2019, titled "Sun Pharma Announces Licensing Agreement With CSIR-IICT".
Final • Div/Share: ₹ 2